Normal view
-
cs.AI, q-bio.NC updates on arXiv.org
-
HiF-DTA: Hierarchical Feature Learning Network for Drug-Target Affinity Prediction
arXiv:2510.27281v1 Announce Type: cross Abstract: Accurate prediction of Drug-Target Affinity (DTA) is crucial for reducing experimental costs and accelerating early screening in computational drug discovery. While sequence-based deep learning methods avoid reliance on costly 3D structures, they still overlook simultaneous modeling of global sequence semantic features and local topological structural features within drugs and proteins, and represent drugs as flat sequences without atomic-level,
-
cs.AI, q-bio.NC updates on arXiv.org
-
A Comprehensive Survey on Reinforcement Learning-based Agentic Search: Foundations, Roles, Optimizations, Evaluations, and Applications
arXiv:2510.16724v2 Announce Type: replace Abstract: The advent of large language models (LLMs) has transformed information access and reasoning through open-ended natural language interaction. However, LLMs remain limited by static knowledge, factual hallucinations, and the inability to retrieve real-time or domain-specific information. Retrieval-Augmented Generation (RAG) mitigates these issues by grounding model outputs in external evidence, but traditional RAG pipelines are often single turn
A Comprehensive Survey on Reinforcement Learning-based Agentic Search: Foundations, Roles, Optimizations, Evaluations, and Applications
-
Omics In Lung
-
Decoding the tumor immune microenvironment in lung squamous cell carcinoma: characteristics, regulatory mechanisms, and future directions in immunotherapy
Transl Lung Cancer Res. 2025 Sep 30;14(9):4112-4130. doi: 10.21037/tlcr-2025-350. Epub 2025 Sep 18.ABSTRACTLung squamous cell carcinoma (LUSC), a predominant type of lung cancer, is marked by an unfavorable prognosis and limited therapeutic options. Unlike lung adenocarcinoma (LUAD), LUSC exhibits few driver mutations, resulting in minimal benefits from targeted therapies for these patients. Despite the transformative effects of immunotherapy on patient outcomes, only a subset of patients achiev
Decoding the tumor immune microenvironment in lung squamous cell carcinoma: characteristics, regulatory mechanisms, and future directions in immunotherapy
Transl Lung Cancer Res. 2025 Sep 30;14(9):4112-4130. doi: 10.21037/tlcr-2025-350. Epub 2025 Sep 18.
ABSTRACT
Lung squamous cell carcinoma (LUSC), a predominant type of lung cancer, is marked by an unfavorable prognosis and limited therapeutic options. Unlike lung adenocarcinoma (LUAD), LUSC exhibits few driver mutations, resulting in minimal benefits from targeted therapies for these patients. Despite the transformative effects of immunotherapy on patient outcomes, only a subset of patients achieving durable responses. This heterogeneity in treatment outcomes is increasingly attributed to the complex feature of the tumor immune microenvironment (TIME) in LUSC. The TIME of LUSC is a highly dynamic ecosystem composed of diverse immune cell populations and stromal components that collectively foster an immune-evasive niche. Recent breakthroughs in multi-omics technologies, particularly single-cell RNA sequencing (scRNA-seq) and spatial omics, have provided unprecedented resolution in dissecting the cellular and molecular architecture of the TIME in LUSC. These technologies have enabled the identification of distinct immune cells and their spatial interactions with the tumor, shedding light on the mechanisms underlying immune evasion and resistance to immunotherapy. Building on these advancements, this review establishes a new classification of the TIME which may guide patient stratification and personalized immunotherapy. And we comprehensively offer a detailed examination of the principal characteristics and regulatory mechanisms of the TIME, highlighting potential immunotherapeutic strategies tailored to this distinct immunological context.
PMID:41133013 | PMC:PMC12541881 | DOI:10.21037/tlcr-2025-350
-
Nature Medicine
-
Building the world’s first truly global medical foundation model
Nature Medicine, Published online: 08 September 2025; doi:10.1038/s41591-025-03859-5Building the world’s first truly global medical foundation model
Building the world’s first truly global medical foundation model
Nature Medicine, Published online: 08 September 2025; doi:10.1038/s41591-025-03859-5
Building the world’s first truly global medical foundation model-
Pulmonary nodule
-
A multiomics dataset of paired CT image and plasma cell-free DNA end motif for patients with pulmonary nodules
Sci Data. 2025 Apr 1;12(1):545. doi: 10.1038/s41597-025-04912-1.ABSTRACTDiagnosing lung cancer at a curable stage offers the opportunity for a favorable prognosis. The emerging epigenomics analysis on plasma cell-free DNA (cfDNA), including 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) modifications, has acted as a promising approach facilitating the identification of lung cancer. And, integrating 5mC biomarker with chest computed tomography (CT) image features could optimize the dia
A multiomics dataset of paired CT image and plasma cell-free DNA end motif for patients with pulmonary nodules
Sci Data. 2025 Apr 1;12(1):545. doi: 10.1038/s41597-025-04912-1.
ABSTRACT
Diagnosing lung cancer at a curable stage offers the opportunity for a favorable prognosis. The emerging epigenomics analysis on plasma cell-free DNA (cfDNA), including 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) modifications, has acted as a promising approach facilitating the identification of lung cancer. And, integrating 5mC biomarker with chest computed tomography (CT) image features could optimize the diagnosis of lung cancer, exceeding the performance of models built on single feature. However, the clinical applicability of integrated markers might be limited by the potential risk of overfitting due to small sample size. Hence, we prospectively collected peripheral blood sample and the paired chest CT images of 2032 patients with indeterminate pulmonary nodules across 5 centers, and constructed a large-scale, multi-institutional, multiomics database that encompass CT imaging data and plasma cfDNA fragmentomic in 5mC-, 5hmC-enriched regions. To our best knowledge, this dataset is the first radio-epigenomic dataset with the largest sample size, and provides multi-dimensional insights for early diagnosis of lung cancer, facilitating the individuated management for lung cancer.
PMID:40169596 | PMC:PMC11961589 | DOI:10.1038/s41597-025-04912-1
-
Nature - Issue - nature.com science feeds
-
Author Correction: π-HuB: the proteomic navigator of the human body
Nature, Published online: 23 December 2024; doi:10.1038/s41586-024-08555-xAuthor Correction: π-HuB: the proteomic navigator of the human body
Author Correction: π-HuB: the proteomic navigator of the human body
Nature, Published online: 23 December 2024; doi:10.1038/s41586-024-08555-x
Author Correction: π-HuB: the proteomic navigator of the human body-
Cell Death Discovery nature.com science feeds
-
Immunometabolism in cancer: basic mechanisms and new targeting strategy
Cell Death Discovery, Published online: 16 May 2024; doi:10.1038/s41420-024-02006-2Immunometabolism in cancer: basic mechanisms and new targeting strategy
Immunometabolism in cancer: basic mechanisms and new targeting strategy
Cell Death Discovery, Published online: 16 May 2024; doi:10.1038/s41420-024-02006-2
Immunometabolism in cancer: basic mechanisms and new targeting strategy-
Oncogene - Issue - nature.com science feeds
-
WNT2–SOX4 positive feedback loop promotes chemoresistance and tumorigenesis by inducing stem-cell like properties in gastric cancer
Oncogene, Published online: 26 August 2023; doi:10.1038/s41388-023-02816-1WNT2–SOX4 positive feedback loop promotes chemoresistance and tumorigenesis by inducing stem-cell like properties in gastric cancer
WNT2–SOX4 positive feedback loop promotes chemoresistance and tumorigenesis by inducing stem-cell like properties in gastric cancer
Oncogene, Published online: 26 August 2023; doi:10.1038/s41388-023-02816-1
WNT2–SOX4 positive feedback loop promotes chemoresistance and tumorigenesis by inducing stem-cell like properties in gastric cancer-
Oncogenesis - nature.com science feeds
-
Methylation of HBP1 by PRMT1 promotes tumor progression by regulating actin cytoskeleton remodeling
Oncogenesis, Published online: 08 August 2022; doi:10.1038/s41389-022-00421-7Methylation of HBP1 by PRMT1 promotes tumor progression by regulating actin cytoskeleton remodeling
Methylation of HBP1 by PRMT1 promotes tumor progression by regulating actin cytoskeleton remodeling
Oncogenesis, Published online: 08 August 2022; doi:10.1038/s41389-022-00421-7
Methylation of HBP1 by PRMT1 promotes tumor progression by regulating actin cytoskeleton remodeling